Atienza-Navarro, I., Marco, Á. d., Alves-Martínez, P., Garcia‑Perez, M. d. l. A., Raya‑Marin, A., Benavente-Fernandez, I., . . . García-Alloza, M. (2024). Glycogen synthase kinase‑3β inhibitor VP3.15 ameliorates neurogenesis, neuronal loss and cognitive impairment in a model of germinal matrix‑intraventricular hemorrhage of the preterm newborn.
Citação norma ChicagoAtienza-Navarro, Isabel, et al. Glycogen Synthase Kinase‑3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix‑intraventricular Hemorrhage of the Preterm Newborn. 2024.
Citação norma MLAAtienza-Navarro, Isabel, et al. Glycogen Synthase Kinase‑3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix‑intraventricular Hemorrhage of the Preterm Newborn. 2024.